Reply to: Do T/B lymphocytes mask the protective effects of group 1 innate lymphoid cells against liver graft ischemia-reperfusion injury?

Affiliations

¹ The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Surgery, Medical University of South Carolina, Charleston, SC 29425.
³ The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; Department of Surgery, Medical University of South Carolina, Charleston, SC 29425. Electronic address: zhaiy@musc.edu.

Hidenobu Kojima et al. Am J Transplant. 2025.

. 2025 Sep 25:S1600-6135(25)02994-6.

doi: 10.1016/j.ajt.2025.09.014. Online ahead of print.

¹ The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Surgery, Medical University of South Carolina, Charleston, SC 29425.
³ The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095; Department of Surgery, Medical University of South Carolina, Charleston, SC 29425. Electronic address: zhaiy@musc.edu.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The authors have declared that no conflict of interest exists.